Eyenovia Inc (EYEN)
0.8625
-0.15
(-14.60%)
USD |
NASDAQ |
May 06, 16:00
0.8625
0.00 (0.00%)
After-Hours: 18:24
Eyenovia Revenue (Annual): 0.0038M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 0.0038M |
December 31, 2022 |
Date | Value |
---|---|
December 31, 2021 | 14.00M |
December 31, 2020 | 2.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.0038M
Minimum
2023
14.00M
Maximum
2021
5.335M
Average
2.00M
Median
2020
Revenue (Annual) Benchmarks
NovaBay Pharmaceuticals Inc | 14.73M |
Alpine Immune Sciences Inc | 58.88M |
Lantern Pharma Inc | -- |
Oragenics Inc | -- |
MAIA Biotechnology Inc | -- |